Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Otolaryngology (Ear, Nose, Throat) | Pulmonary/Respiratory Diseases | Immunology | Infections and Infectious Diseases
Disease Category: Allergy
Location: United States, NY
Clinical Trial Details
Research Study Summary
Study for adults with Hereditary Angioedema (HAE)
Winthrop University Hospital Clinical Trials Center is seeking volunteers with inadequately controlled Hereditary Angioedema (HAE) for a clinical research study to test a medication already approved by the Food and Drug Administration (FDA) to investigate the safety and effectiveness of a higher dosage not approved by the FDA.
Patient Inclusion Criteria:
Eligible participants will receive study-related medication and medical care at no cost to them. Compensation travel expenses may also be available.
- diagnosis of HAE with a documented history of swelling
- have a history of an average of more than one HAE attack each month of any severity
- must be receiving the recommended CINRYZE™ (c1 Esterase Inhibitor [Human]) dosing of 1000 U every three to four days via intravenous injection
Patient Exclusion Criteria:
To Learn more
Both Male and Female
Date Last Changed:
July 23, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.